Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ITGR logo ITGR
Upturn stock ratingUpturn stock rating
ITGR logo

Integer Holdings Corp (ITGR)

Upturn stock ratingUpturn stock rating
$107.38
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: ITGR (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

10 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $140.88

1 Year Target Price $140.88

Analysts Price Target For last 52 week
$140.88 Target price
52w Low $104.93
Current$107.38
52w High $146.36

Analysis of Past Performance

Type Stock
Historic Profit 23.8%
Avg. Invested days 76
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.76B USD
Price to earnings Ratio 45.89
1Y Target Price 140.88
Price to earnings Ratio 45.89
1Y Target Price 140.88
Volume (30-day avg) 10
Beta 1.02
52 Weeks Range 104.93 - 146.36
Updated Date 08/29/2025
52 Weeks Range 104.93 - 146.36
Updated Date 08/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 2.34

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 4.61%
Operating Margin (TTM) 13.42%

Management Effectiveness

Return on Assets (TTM) 4.6%
Return on Equity (TTM) 5.15%

Valuation

Trailing PE 45.89
Forward PE 19.72
Enterprise Value 5060013649
Price to Sales(TTM) 2.1
Enterprise Value 5060013649
Price to Sales(TTM) 2.1
Enterprise Value to Revenue 2.82
Enterprise Value to EBITDA 17.97
Shares Outstanding 35034800
Shares Floating 34635770
Shares Outstanding 35034800
Shares Floating 34635770
Percent Insiders 1.19
Percent Institutions 116.09

ai summary icon Upturn AI SWOT

Integer Holdings Corp

stock logo

Company Overview

overview logo History and Background

Integer Holdings Corp. was founded in 1934 as Greatbatch, Inc., initially focused on battery technology. Over time, it evolved into a medical device outsource manufacturer, expanding its capabilities through strategic acquisitions and organic growth. The company rebranded as Integer Holdings Corp. in 2016 to reflect its broader focus and capabilities.

business area logo Core Business Areas

  • Medical: This segment develops and manufactures medical devices and components for cardiovascular, neuromodulation, orthopedics, and other therapeutic areas. It includes products like leads, delivery systems, and complex surgical tools.
  • Cardio & Vascular: Focuses on cardiac rhythm management, electrophysiology, vascular, and structural heart markets. Products include pacing leads, guidewires, and delivery systems.
  • Advanced Surgical: Provides high-precision components, minimally invasive surgical tools, and instruments.
  • Power Solutions: Designs and manufactures batteries and energy storage solutions for medical, industrial, and military applications.

leadership logo Leadership and Structure

Integer Holdings Corp. is led by a CEO and a senior management team responsible for overseeing the company's operations and strategy. The organizational structure typically includes functional departments such as finance, operations, sales, and marketing.

Top Products and Market Share

overview logo Key Offerings

  • Cardiac Rhythm Management (CRM) Leads: Integer is a major supplier of CRM leads, including pacing and defibrillation leads. Their market share is significant, though specific figures fluctuate. Competitors include Medtronic (MDT), Abbott (ABT), and Boston Scientific (BSX). Integer produces a wide range of specialized medical device leads with advanced components, which they design and manufacture for their customers.
  • Advanced Surgical Tools and Components: They manufacture minimally invasive surgical tools, components, and instruments. Revenue varies depending on customer demand and project timelines, but is a substantial portion of overall revenue. Competitors include Te Connectivity (TEL), Stryker (SYK), and Smith & Nephew (SNN).
  • Medical Batteries: Integer designs and manufactures batteries and energy storage solutions for implantable medical devices. Competitors include EaglePicher Technologies and Saft. Number of units vary greatly. Market share for these products depends on the specific battery types. Integer produces a wide range of energy storage solutions.

Market Dynamics

industry overview logo Industry Overview

The medical device outsourcing industry is experiencing growth, driven by increasing demand for medical devices, cost pressures on device manufacturers, and technological advancements.

Positioning

Integer Holdings Corp. is positioned as a leading medical device outsource manufacturer, with a focus on innovation, quality, and customer service. They serve major medical device OEMs and offer vertically integrated solutions.

Total Addressable Market (TAM)

The global medical device outsourcing market is projected to reach hundreds of billions of USD. Integer's positioning as a key supplier allows it to capture a significant portion of this market. Integer services multiple markets.

Upturn SWOT Analysis

Strengths

  • Strong market position as a leading medical device outsource manufacturer
  • Broad portfolio of products and services
  • Vertically integrated capabilities
  • Long-standing relationships with major medical device OEMs
  • Focus on innovation and quality

Weaknesses

  • Customer concentration
  • Exposure to regulatory changes
  • Dependence on key suppliers
  • Competition from other outsource manufacturers
  • Vulnerability to economic downturns

Opportunities

  • Growth in emerging markets
  • Increasing demand for minimally invasive procedures
  • Technological advancements in medical devices
  • Expansion of product offerings
  • Strategic acquisitions

Threats

  • Intensifying competition
  • Pricing pressure from customers
  • Product liability claims
  • Economic uncertainty
  • Supply chain disruptions

Competitors and Market Share

competitor logo Key Competitors

  • Medtronic (MDT)
  • TE Connectivity (TEL)
  • Boston Scientific (BSX)
  • Abbott (ABT)

Competitive Landscape

Integer competes on factors such as price, quality, innovation, and customer service. Their vertically integrated capabilities and strong relationships with OEMs provide a competitive advantage.

Major Acquisitions

Oscor Medical

  • Year: 2020
  • Acquisition Price (USD millions): 220
  • Strategic Rationale: Expanded Integer's CRM and neuromodulation capabilities.

Growth Trajectory and Initiatives

Historical Growth: Integer has experienced consistent growth over the past few years, driven by increasing demand for medical devices and outsourcing services.

Future Projections: Analysts anticipate continued growth for Integer, supported by favorable industry trends and strategic initiatives.

Recent Initiatives: Recent strategic initiatives include acquisitions to expand capabilities and market reach, investments in research and development, and operational improvements to enhance efficiency.

Summary

Integer Holdings Corp. is a strong player in the medical device outsourcing market, driven by its comprehensive services and long-standing relationships. Increasing revenues and strategic acquisitions highlight their commitment to growth. However, competition and customer concentration require ongoing vigilance. Integer's focus on innovation and quality positions them well for future success within the industry.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Integer Holdings Corp. Investor Relations
  • SEC Filings (10-K, 10-Q)
  • Industry Reports
  • Analyst Estimates

Disclaimers:

This analysis is based on publicly available information and analyst estimates. Actual results may vary. This is not financial advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Integer Holdings Corp

Exchange NYSE
Headquaters Plano, TX, United States
IPO Launch date 2000-09-29
President, CEO & Director Mr. Joseph W. Dziedzic
Sector Healthcare
Industry Medical Devices
Full time employees 11000
Full time employees 11000

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Plano, Texas.